Effect of Rebamipide on Low-grade Inflammation in Post COVID-19 Syndrome Patients 🔗 Access full article via Journal of Allergy and Clinical ImmunologyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
